Sébastien Desprez becomes head of IR at Adaptimmune

Company: Adaptimmune Therapeutics Plc

Appointee: Sébastien Desprez


United Kingdom

Sébastien Desprez has joined Adaptimmune Therapeutics Plc from ViiV Healthcare to direct communications and investor relations. Adaptimmune has a clinical-stage portfolio of cancer products based on engineered T cell receptors. Prior to working at ViiV, Mr Desprez managed communications for the oncology unit of GlaxoSmithKline Plc.

Adaptimmune announced the appointment on 23 October 2017.

Copyright 2017 Evernow Publishing Ltd.